Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models

Surgery followed by a chemotherapy agent is the first-line treatment for breast cancer patients. Nevertheless, new targets are required for women with triple-negative breast cancer (TNBC) in order to improve the treatment of this aggressive cancer subtype. Multiple pro-inflammatory molecules includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupp, Tristan, Pelouin, Océane, Genest, Laurie, Legrand, Christophe, Froget, Guillaume, Castagné, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649527/
https://www.ncbi.nlm.nih.gov/pubmed/33157518
http://dx.doi.org/10.1016/j.tranon.2020.100926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649527/
https://www.ncbi.nlm.nih.gov/pubmed/33157518
http://dx.doi.org/10.1016/j.tranon.2020.100926

Ejemplares similares